VITROLIFE AB SK 0,2 revenue for the last year amounted to 313.76 M EUR, the most of which — 129.97 M EUR — came from its highest performing source at the moment, Genetic, the year earlier bringing 120.18 M EUR. The greatest contribution to the revenue figure was made by EMEA — last year it brought VITROLIFE AB SK 0,2 95.98 M EUR, and the year before that — 94.52 M EUR.